Zylox Medical

Zylox-Tonbridge Medical Technology Co., Ltd. is a China-based, publicly-traded company specializing in the neurovascular and peripheral interventional medical device market. The company was founded in November 2012 by Dr. Jonathon Zhong Zhao, who serves as Chairman and CEO. Dr. Zhao has over two decades of experience in the pharmaceutical and medical device industries, including R&D on drug-eluting stents and drug-coated balloons.

The company was established in Hangzhou as Zylox Medical Devices Co., Ltd., initially focusing on peripheral vascular intervention. In 2016, Zhuhai Ton-Bridge Medical Tech was founded to focus on neurovascular intervention. The two companies officially merged in 2018, creating Zylox-Tonbridge Medical Technology Co, Ltd. A significant milestone was achieved on July 5, 2021, when the company was listed on the Main Board of the Hong Kong Stock Exchange under the stock code 2190.HK.

Zylox-Tonbridge operates as a fully integrated medical device company with strong in-house research and development, manufacturing, and commercialization capabilities. Its business model focuses on providing a comprehensive portfolio of solutions for physicians and patients. Revenue is generated through the sale of its medical devices, with a distribution network covering over 3,000 hospitals in China and a growing international presence. The company's product portfolio includes over 60 products and candidates, such as the Thrombite™ Clot Retriever Device, Ultrafree™ Drug Coated PTA Balloon Catheter, and the Kylin™ Flow Diverter. The company also engages in strategic partnerships, such as its collaboration with Avinger, Inc. to commercialize OCT imaging-guided devices in Greater China and leverage cost-efficient manufacturing for global sales.

Keywords: neurovascular intervention, peripheral vascular devices, interventional medical devices, drug-coated balloon, clot retriever, flow diverter, medical device manufacturing, peripheral artery disease, ischemic stroke, hemorrhagic stroke, aneurysm treatment, embolization coils, PTA balloon catheter, venous stents, vascular closure device, medical technology, surgical devices, therapeutic devices, revascularization, angiography.